Potential beneficial effects of masupirdine (SUVN‐502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses-Reference-Cited by-同舟云学术

Potential beneficial effects of masupirdine (SUVN‐502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses

Published:2022-09-27 Issue:10 Volume:37 Page:
ISSN:0885-6230
Container-title:International Journal of Geriatric Psychiatry
language:en
Short-container-title:Int J Geriat Psychiatry

Author:

Nirogi Ramakrishna¹,Jayarajan Pradeep¹,Benade Vijay¹,Shinde Anil¹,Goyal Vinod Kumar¹,Jetta Satish¹,Ravula Jyothsna¹,Abraham Renny¹,Grandhi Venkata Ramalingayya¹,Subramanian Ramkumar¹,Pandey Santosh Kumar¹,Badange Rajesh Kumar¹,Mohammed Abdul Rasheed¹,Jasti Venkat¹,Ballard Clive²,Cummings Jeffrey³^ORCID

Affiliation:

1. Suven Life Sciences Limited Hyderabad Telangana India

2. University of Exeter Medical School Exeter UK

3. Department of Brain Health Chambers‐Grundy Center for Transformative Neuroscience School of Integrated Health Sciences University of Nevada Las Vegas Nevada USA

Funder

Alzheimer's Drug Discovery Foundation

National Institute of Neurological Disorders and Stroke

National Institute on Aging

National Institute of General Medical Sciences

Publisher

Wiley

Subject

Psychiatry and Mental health,Geriatrics and Gerontology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/gps.5813

Reference53 articles.